20. Jacobson JL, Jacobson SW, Humphrey HE (1996) Intellectual impairment in children exposed
to polychlorinated biphenyls In Utero. N Engl J Med 335:783–789
21. Gladen BC, Rogan WJ (1991) Effects of perinatal polychlorinated biphenyls and
dichlorodiphenyl dichloroethene on later development. J Pediatr 113:991–995
22. Huisman MC, Koopman-Esseboom V, Fidler M, Hadders-Algra CG, can der Paauw LG,
Tinstra N, Weisglas-Kuperus PJ, Sauer BC, Boersma ER (1995) Perinatal exposure to
polychlorinated biphenyls and dioxins and its effect on neonatal neurological development.
Early Hum Develop 41:111–127
23. Brouwer A, Longnecker MP, Birnbaum LS, Cogliano J, Kostyniak P, Moore J, Schantz S,
Winneke G (1999) Characterization of potential endocrine-related health effects at low-dose
levels of exposure to PCBs. Environ Health Perspect 107(suppl 4):639–649
24. Tohyama C (2004) Mechanisms of dioxin toxicity: implications for assessing risk to humans,
conference on Environmental Endocrine Disruptors. Colby-Sawyer College, New London, CT,
USA, pp 6–11
25. U.S. Department of Health and Human Services (2001) 2,3,7,8-Tetracblorodibenzo p-Dioxin
(TCDD); DIOXIN, CAS No.1746-01-6, Public Health Service National Toxicology Program,
USA, 9th Report on Carcinogens, January
26. U. S. Department of Health and Human Services (2001) Furan, CAS No. 110–00-9. 9th Report
on Carcinogens, Public Health Service National Toxicology Program, USA, January
27. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP (1995) A variety of environmentally
persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ
Health Perspect 103(6):582–587
28. Maguire RJ (1999) Review of the persistence of nonylphenol and nonylphenol ethoxylates in
aquatic environments. Water Qual Res J Can 34(1):37–78
29. Hauser R (2004) Phthalates: understanding human exposure and health risks, Conference on
Environmental Endocrine Disruptors. Colby-Sawyer College, New London, CT, USA, pp 6–11
30. Colón I, Caro D, Bourdony CJ, Rosario O (2000) Identification of phthalate esters in the serum
of young Puerto Rican girls with premature breast development. Environ Health Perspect 108:9
31. AWWA, ASCE (1998) Water treatment plant design, 3rd edn. McGraw-Hill Company, Inc,
New York, USA
32. U. S. EPA (1990) Technologies for upgrading existing or designing new drinking water
treatment facilities, EPA/625/4–89/023. U. S. Environmental Protection Agency, USA
33. U. S. EPA (1997) Water on tap: a consumer’s guide to the nation’s drinking water, EPA/815/K97/002. U. S. Environmental Protection Agency, USA
34. U. S. EPA (1998) Small system compliance technology list for the non-microbial contaminants
regulated before 1996, EPA/815/R-98/002. U. S. Environmental Protection Agency
35. U. S. EPA (1999) Drinking water treatment, EPA/810/F-99/013. U. S. Environmental Protection Agency, USA
36. Wang LK (2005) In: Hung YT, Shammas NK (eds) Physicochemical treatment processes. The
Humana Press, Inc., Totowa, NJ, USA
37. Wang, L. K, Hung, Y. T. and Shammas, N. K. (eds.) Advanced physicochemical treatment
processes, The Humana Press, Inc., Totowa, NJ, USA (2005)
38. Hung YT, Lo HH, Wang LK, Taricska JR, Li KH (2005) Granular activated carbon adsorption.
In: Wang LK, Hung YT, Shammas NK (eds) Physicochemical treatment processes. The
Humana Press, Inc., Totowa, NJ, USA
39. Shammas NK (2005) Coagulation and flocculation. In: Wang LK, Hung YT, Shammas NK
(eds) Physicochemical treatment processes. The Humana Press, Inc., Totowa, NJ, USA
40. Hung YT, Taricska JR, Lo HH, Wang LK, Li KH (2005) Powdered activated carbon adsorption. In: Wang LK, Hung YT, Shammas NK (eds) Advanced physicochemical treatment
processes. The Humana Press, Inc., Totowa, NJ, USA
41. Endocrine Disruptor knowledge Base (EDKB), Resources to Predict Estrogen and Androgen
Activity, National Center for Toxicological Research, U.S. Food and Drug Administration,
USA (2014)
4 Endocrine Disruptors
193
to polychlorinated biphenyls In Utero. N Engl J Med 335:783–789
21. Gladen BC, Rogan WJ (1991) Effects of perinatal polychlorinated biphenyls and
dichlorodiphenyl dichloroethene on later development. J Pediatr 113:991–995
22. Huisman MC, Koopman-Esseboom V, Fidler M, Hadders-Algra CG, can der Paauw LG,
Tinstra N, Weisglas-Kuperus PJ, Sauer BC, Boersma ER (1995) Perinatal exposure to
polychlorinated biphenyls and dioxins and its effect on neonatal neurological development.
Early Hum Develop 41:111–127
23. Brouwer A, Longnecker MP, Birnbaum LS, Cogliano J, Kostyniak P, Moore J, Schantz S,
Winneke G (1999) Characterization of potential endocrine-related health effects at low-dose
levels of exposure to PCBs. Environ Health Perspect 107(suppl 4):639–649
24. Tohyama C (2004) Mechanisms of dioxin toxicity: implications for assessing risk to humans,
conference on Environmental Endocrine Disruptors. Colby-Sawyer College, New London, CT,
USA, pp 6–11
25. U.S. Department of Health and Human Services (2001) 2,3,7,8-Tetracblorodibenzo p-Dioxin
(TCDD); DIOXIN, CAS No.1746-01-6, Public Health Service National Toxicology Program,
USA, 9th Report on Carcinogens, January
26. U. S. Department of Health and Human Services (2001) Furan, CAS No. 110–00-9. 9th Report
on Carcinogens, Public Health Service National Toxicology Program, USA, January
27. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP (1995) A variety of environmentally
persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ
Health Perspect 103(6):582–587
28. Maguire RJ (1999) Review of the persistence of nonylphenol and nonylphenol ethoxylates in
aquatic environments. Water Qual Res J Can 34(1):37–78
29. Hauser R (2004) Phthalates: understanding human exposure and health risks, Conference on
Environmental Endocrine Disruptors. Colby-Sawyer College, New London, CT, USA, pp 6–11
30. Colón I, Caro D, Bourdony CJ, Rosario O (2000) Identification of phthalate esters in the serum
of young Puerto Rican girls with premature breast development. Environ Health Perspect 108:9
31. AWWA, ASCE (1998) Water treatment plant design, 3rd edn. McGraw-Hill Company, Inc,
New York, USA
32. U. S. EPA (1990) Technologies for upgrading existing or designing new drinking water
treatment facilities, EPA/625/4–89/023. U. S. Environmental Protection Agency, USA
33. U. S. EPA (1997) Water on tap: a consumer’s guide to the nation’s drinking water, EPA/815/K97/002. U. S. Environmental Protection Agency, USA
34. U. S. EPA (1998) Small system compliance technology list for the non-microbial contaminants
regulated before 1996, EPA/815/R-98/002. U. S. Environmental Protection Agency
35. U. S. EPA (1999) Drinking water treatment, EPA/810/F-99/013. U. S. Environmental Protection Agency, USA
36. Wang LK (2005) In: Hung YT, Shammas NK (eds) Physicochemical treatment processes. The
Humana Press, Inc., Totowa, NJ, USA
37. Wang, L. K, Hung, Y. T. and Shammas, N. K. (eds.) Advanced physicochemical treatment
processes, The Humana Press, Inc., Totowa, NJ, USA (2005)
38. Hung YT, Lo HH, Wang LK, Taricska JR, Li KH (2005) Granular activated carbon adsorption.
In: Wang LK, Hung YT, Shammas NK (eds) Physicochemical treatment processes. The
Humana Press, Inc., Totowa, NJ, USA
39. Shammas NK (2005) Coagulation and flocculation. In: Wang LK, Hung YT, Shammas NK
(eds) Physicochemical treatment processes. The Humana Press, Inc., Totowa, NJ, USA
40. Hung YT, Taricska JR, Lo HH, Wang LK, Li KH (2005) Powdered activated carbon adsorption. In: Wang LK, Hung YT, Shammas NK (eds) Advanced physicochemical treatment
processes. The Humana Press, Inc., Totowa, NJ, USA
41. Endocrine Disruptor knowledge Base (EDKB), Resources to Predict Estrogen and Androgen
Activity, National Center for Toxicological Research, U.S. Food and Drug Administration,
USA (2014)
4 Endocrine Disruptors
193
